Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blood-circulating EV-miRNAs, serum TARC, and quantitative FDG-PET features in classical Hodgkin lymphoma.
Drees EEE, Driessen J, Zwezerijnen GJC, Verkuijlen SAWM, Eertink JJ, van Eijndhoven MAJ, Groenewegen NJ, Vallés-Martí A, de Jong D, Boellaard R, de Vet HCW, Pegtel DM, Zijlstra JM. Drees EEE, et al. Among authors: eertink jj. EJHaem. 2022 Apr 28;3(3):908-912. doi: 10.1002/jha2.432. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051072 Free PMC article.
Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium.
Barrington SF, Zwezerijnen BGJC, de Vet HCW, Heymans MW, Mikhaeel NG, Burggraaff CN, Eertink JJ, Pike LC, Hoekstra OS, Zijlstra JM, Boellaard R. Barrington SF, et al. Among authors: eertink jj. J Nucl Med. 2021 Mar;62(3):332-337. doi: 10.2967/jnumed.119.238923. Epub 2020 Jul 17. J Nucl Med. 2021. PMID: 32680929 Free PMC article.
Interobserver Agreement on Automated Metabolic Tumor Volume Measurements of Deauville Score 4 and 5 Lesions at Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma.
Zwezerijnen GJC, Eertink JJ, Burggraaff CN, Wiegers SE, Shaban EAIN, Pieplenbosch S, Oprea-Lager DE, Lugtenburg PJ, Hoekstra OS, de Vet HCW, Zijlstra JM, Boellaard R. Zwezerijnen GJC, et al. Among authors: eertink jj. J Nucl Med. 2021 Nov;62(11):1531-1536. doi: 10.2967/jnumed.120.258673. Epub 2021 Mar 5. J Nucl Med. 2021. PMID: 33674403 Free PMC article.
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients.
Eertink JJ, Burggraaff CN, Heymans MW, Dührsen U, Hüttmann A, Schmitz C, Müller S, Lugtenburg PJ, Barrington SF, Mikhaeel NG, Carr R, Czibor S, Györke T, Ceriani L, Zucca E, Hutchings M, Kostakoglu L, Loft A, Fanti S, Wiegers SE, Pieplenbosch S, Boellaard R, Hoekstra OS, Zijlstra JM, de Vet HCW. Eertink JJ, et al. Blood Adv. 2021 May 11;5(9):2375-2384. doi: 10.1182/bloodadvances.2021004467. Blood Adv. 2021. PMID: 33944897 Free PMC article.
18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma.
Eertink JJ, van de Brug T, Wiegers SE, Zwezerijnen GJC, Pfaehler EAG, Lugtenburg PJ, van der Holt B, de Vet HCW, Hoekstra OS, Boellaard R, Zijlstra JM. Eertink JJ, et al. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):932-942. doi: 10.1007/s00259-021-05480-3. Epub 2021 Aug 18. Eur J Nucl Med Mol Imaging. 2022. PMID: 34405277 Free PMC article.
Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements.
Eertink JJ, Arens AIJ, Huijbregts JE, Celik F, de Keizer B, Stroobants S, de Jong D, Wiegers SE, Zwezerijnen GJC, Burggraaff CN, Boellaard R, de Vet HCW, Hoekstra OS, Lugtenburg PJ, Chamuleau MED, Zijlstra JM; HOVON imaging workgroup. Eertink JJ, et al. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):943-952. doi: 10.1007/s00259-021-05498-7. Epub 2021 Sep 2. Eur J Nucl Med Mol Imaging. 2022. PMID: 34476551 Free PMC article.
A Guide to ComBat Harmonization of Imaging Biomarkers in Multicenter Studies.
Orlhac F, Eertink JJ, Cottereau AS, Zijlstra JM, Thieblemont C, Meignan M, Boellaard R, Buvat I. Orlhac F, et al. Among authors: eertink jj. J Nucl Med. 2022 Feb;63(2):172-179. doi: 10.2967/jnumed.121.262464. Epub 2021 Sep 16. J Nucl Med. 2022. PMID: 34531263 Free PMC article.
18F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B-Cell Lymphoma: The HOVON-84 Study.
Burggraaff CN, Eertink JJ, Lugtenburg PJ, Hoekstra OS, Arens AIJ, de Keizer B, Heymans MW, van der Holt B, Wiegers SE, Pieplenbosch S, Boellaard R, de Vet HCW, Zijlstra JM; HOVON Imaging Working Group and the HOVON Lymphoma Working Group. Burggraaff CN, et al. Among authors: eertink jj. J Nucl Med. 2022 Jul;63(7):1001-1007. doi: 10.2967/jnumed.121.262205. Epub 2021 Oct 21. J Nucl Med. 2022. PMID: 34675112 Free PMC article. Clinical Trial.
Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma.
Greuter M, Eertink JJ, Jongeneel G, Dührsen U, Hüttmann A, Schmitz C, Lugtenburg PJ, Barrington SF, Mikhaeel NG, Ceriani L, Zucca E, Carr R, Györke T, Burggraaff CN, de Vet H, Hoekstra OS, Zijlstra JM, Coupé V; PETRA consortium. Greuter M, et al. Among authors: eertink jj. Clin Lymphoma Myeloma Leuk. 2022 Jun;22(6):382-392. doi: 10.1016/j.clml.2021.11.008. Epub 2021 Nov 20. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34953740 Free article.
25 results